BioAdaptives (OTC: BDPT) announced the launch of MyndRenew(TM), a nighttime dietary supplement designed to support sleep quality and the brain’s overnight recovery processes, addressing what the company describes as a critical gap in cognitive health as more than one-third of U.S. adults report insufficient sleep. MyndRenew(TM) is part of the MyndSystem(TM) platform, which targets full 24-hour cognitive support, with formulations tailored to both daytime performance and nighttime recovery.

The formulation includes 13 ingredients selected from published scientific literature, including magnesium glycinate, apigenin, PEA and lion’s mane mushroom extract, aimed at supporting sleep pathways, cellular repair, stress regulation and neuroprotection. MyndRenew(TM) complements the company’s daytime product, MyndMed(TM), with both products positioned to address distinct physiological demands across the daily cycle.

To view the full press release, visit https://ibn.fm/jubib

About BioAdaptives, Inc.

BioAdaptives, Inc. develops and markets science-based health and wellness products for human and animal use. Its formulations are rooted in published research across nutrition, adaptogens, and cellular health, with a focus on supporting normal physiological function.

For more information, please visit our website at www.bioadaptives.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

This contant was orignally distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is InvestorNewsBreaks – BioAdaptives, Inc. (OTC: BDPT) Launches MyndRenew Nighttime Supplement for Cognitive Recovery.